Ariel Y. Deutch
#152,526
Most Influential Person Now
Ariel Y. Deutch's AcademicInfluence.com Rankings
Ariel Y. Deutchbiology Degrees
Biology
#11505
World Rank
#14905
Historical Rank
Neuroscience
#1868
World Rank
#1924
Historical Rank
Download Badge
Biology
Why Is Ariel Y. Deutch Influential?
(Suggest an Edit or Addition)Ariel Y. Deutch's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract‐tracing study with Phaseolus vulgaris leucoagglutinin (1989) (1613)
- The patterns of afferent innervation of the core and shell in the “Accumbens” part of the rat ventral striatum: Immunohistochemical detection of retrogradely transported fluoro‐gold (1993) (1094)
- Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models (2006) (710)
- Psychobiologic mechanisms of posttraumatic stress disorder. (1993) (605)
- Anatomical substrates of orexin–dopamine interactions: lateral hypothalamic projections to the ventral tegmental area (2002) (495)
- Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell (1992) (464)
- The determinants of stress-induced activation of the prefrontal cortical dopamine system. (1990) (396)
- Stress and the Mesocorticolimbic Dopamine Systems a (1988) (358)
- Footshock and conditioned stress increase 3, 4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra (1985) (357)
- Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress (1990) (334)
- Hyperexcitability and epilepsy associated with disruption of the mouse neuronal‐specific K–Cl cotransporter gene (2002) (322)
- Serotonin 5‐HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex (1997) (318)
- Mechanisms of action of atypical antipsychotic drugs Implications for novel therapeutic strategies for schizophrenia (1991) (261)
- A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. (1996) (260)
- Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease (2005) (260)
- FETAL NEURONAL GRAFTS IN MONKEYS GIVEN METHYLPHENYLTETRAHYDROPYRIDINE (1986) (243)
- Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action (1992) (240)
- Neurobiological and clinical consequences of stress : from normal adaptation to post-traumatic stress disorder (1995) (236)
- Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats (2008) (228)
- Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection (2008) (220)
- Functional expression and CNS distribution of a β-alanine-sensitive neuronal GABA transporter (1992) (217)
- The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. (1992) (216)
- Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction (2008) (214)
- Telencephalic Projections of the A8 Dopamine Cell Group (1988) (204)
- Differential Activation of Orexin Neurons by Antipsychotic Drugs Associated with Weight Gain (2002) (193)
- Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum (1992) (184)
- Effects of Antipsychotic Drugs on Neurogenesis in the Forebrain of the Adult Rat (2004) (171)
- Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. (1998) (156)
- 5-HT2 Receptor Regulation of Extracellular GABA Levels in the Prefrontal Cortex (1999) (152)
- Dopaminergic mechanisms in the pathogenesis of schizophrenia 1 (1992) (148)
- The effects of antipsychotic drugs on fos protein expression in the prefrontal cortex: Cellular localization and pharmacological characterization (1996) (147)
- DOI-Induced Activation of the Cortex: Dependence on 5-HT2A Heteroceptors on Thalamocortical Glutamatergic Neurons (2000) (146)
- Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. (1987) (145)
- Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. (1991) (142)
- Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease (2005) (131)
- Proteomic analysis illuminates a novel structural definition of the claustrum and insula. (2009) (130)
- Stress induces Fos expression in neurons of the thalamic paraventricular nucleus that innervate limbic forebrain sites (1999) (129)
- Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regions (1989) (127)
- Controlled release of dopamine from a polymeric brain implant: In vivo characterization (1989) (110)
- Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF (1987) (103)
- The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats (2003) (102)
- Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism (2005) (98)
- Amplified ribosomal DNA from Xenopus laevis has heterogeneous spacer lengths. (1974) (98)
- Immunohistochemical localization of a neuronal nicotinic acetylcholine receptor in mammalian brain. (1987) (96)
- Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome (2010) (93)
- Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism. (2007) (91)
- Distribution of Dopamine D2-Like Receptors in the Human Thalamus: Autoradiographic and PET Studies (2004) (90)
- Antipsychotic Drug-Like Effects of the Selective M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator VU0152100 (2014) (88)
- Thalamic paraventricular nucleus neurons collateralize to innervate the prefrontal cortex and nucleus accumbens (1998) (87)
- The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study. (1994) (85)
- Dopamine Depletion of the Prefrontal Cortex Induces Dendritic Spine Loss: Reversal by Atypical Antipsychotic Drug Treatment (2008) (84)
- Dopaminergic regulation of orexin neurons (2005) (82)
- Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action (1995) (81)
- Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons (2007) (80)
- 5‐HT1a agonist ±‐ 8‐OH‐DPAT modulates basal and stress‐induced changes in medial prefrontal cortical dopamine (1994) (80)
- Stoichiometry of Tyrosine Hydroxylase Phosphorylation in the Nigrostriatal and Mesolimbic Systems In Vivo (2000) (77)
- Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes (1992) (76)
- Substance K and substance P differentially modulate mesolimbic and mesocortical systems (1985) (76)
- Microglial Pruning of Synapses in the Prefrontal Cortex During Adolescence (2019) (75)
- Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss. (2010) (75)
- 5-Hydroxytryptamine2C Receptor Contribution to m-Chlorophenylpiperazine and N-Methyl-β-carboline-3-carboxamide-Induced Anxiety-Like Behavior and Limbic Brain Activation (2007) (74)
- The Effects of Thalamic Paraventricular Nucleus Lesions on Cocaine-Induced Locomotor Activity and Sensitization (1998) (74)
- Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems (1992) (73)
- Functional Connectome Analysis of Dopamine Neuron Glutamatergic Connections in Forebrain Regions (2015) (73)
- Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum. (1987) (72)
- Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (1986) (71)
- Psychostimulant-Induced Fos Protein Expression in the Thalamic Paraventricular Nucleus (1998) (71)
- Activation of the locus coeruleus induced by selective stimulation of the ventral tegmental area (1986) (68)
- Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57/Bl6 mice (2008) (63)
- Mild footshock stress dissociates substance P from substance K and dynorphin from Met- and Leu-enkephalin (1986) (62)
- Organization of afferents to the orbitofrontal cortex in the rat (2018) (61)
- Distribution of serotonin 5‐HT2A receptors in afferents of the rat striatum (2001) (61)
- Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions (1987) (58)
- Substance K and substance P in the ventral tegmental area (1985) (57)
- Transplantation of fetal dopamine neurons in primate brain reverses MPTP induced parkinsonism. (1987) (55)
- The Cbln family of proteins interact with multiple signaling pathways (2012) (55)
- The Hippocampal-VTA Loop: The Role of Novelty and Motivation in Controlling the Entry of Information into Long-Term Memory (2013) (54)
- Cortical hierarchy governs rat claustrocortical circuit organization (2017) (52)
- Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson's disease. (2006) (51)
- Neurotensin Activates GABAergic Interneurons in the Prefrontal Cortex (2005) (50)
- Reversal of Parkinsonism by Fetal Nerve Cell Transplants in Primate Brain a (1987) (49)
- The Current Status of Neurotensin‐Dopamine Interactions (1992) (48)
- The Neurotensin Agonist PD149163 Increases Fos Expression in the Prefrontal Cortex of the Rat (2004) (47)
- p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling. (2006) (47)
- A Role for the p75 Neurotrophin Receptor in Axonal Degeneration and Apoptosis Induced by Oxidative Stress* (2014) (47)
- Neurotensin-deficient mice show altered responses to antipsychotic drugs (2001) (46)
- Genetic Inhibition of CaMKII in Dorsal Striatal Medium Spiny Neurons Reduces Functional Excitatory Synapses and Enhances Intrinsic Excitability (2012) (45)
- MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeys (1990) (44)
- Extracerebellar role for Cerebellin1: Modulation of dendritic spine density and synapses in striatal medium spiny neurons (2010) (44)
- MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primate (1990) (44)
- Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation (2009) (44)
- Connecting imaging mass spectrometry and magnetic resonance imaging-based anatomical atlases for automated anatomical interpretation and differential analysis. (2017) (40)
- Cryopreservation of human brain tissue (1990) (39)
- Regulation of the prefrontal cortical dopamine system by the neuroactive steroid 3a,21-dihydroxy-5a-pregnane-20-one (1992) (39)
- Effects of D2 dopamine receptor antagonists on fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate (1996) (39)
- 3-Acetylpyridine-induced degeneration of the nigrostriatal dopamine system: An animal model of olivopontocerebellar atrophy-associated parkinsonism (1989) (38)
- Calcitonin gene-related peptide in the ventral tegmental area: Selective modulation of prefrontal cortical dopamine metabolism (1987) (36)
- Neurotensin: dual roles in psychostimulant and antipsychotic drug responses. (2003) (36)
- The ascending projections of the dopaminergic neurons of the substantia nigra, zona reticulata: a combined retrograde tracer-immunohistochemical study (1986) (35)
- The orexins/hypocretins and schizophrenia. (2006) (35)
- Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice (1989) (33)
- Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum (2002) (32)
- Uptake and utilization of metabolites in specific brain sites relative to feeding status (1986) (30)
- Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration (2007) (30)
- Effects of Desmethylclozapine on Fos Protein Expression in the Forebrain: In Vivo Biological Activity of the Clozapine Metabolite (1998) (29)
- Sites and Mechanisms of Action of Antipsychotic Drugs as Revealed by Immediate-Early Gene Expression (1996) (29)
- Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation (1999) (29)
- The anxiogenic β-carboline FG-7142 increases in vivo and in vitro tyrosine hydroxylation in the prefrontal cortex (1989) (29)
- 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson’s disease (2010) (29)
- The effects of perinatal diazepam exposure on stress-induced activation of the mesotelencephalic dopamine system. (1989) (28)
- Comparison of Cbln1 and Cbln2 functions using transgenic and knockout mice (2012) (27)
- Perinatal diazepam exposure: Alterations in exploratory behavior and mesolimbic dopamine turnover (1990) (27)
- The distribution and origin of the calretinin‐containing innervation of the nucleus accumbens of the rat (2000) (27)
- Dystrophic dendrites in prefrontal cortical pyramidal cells of dopamine D1 and D2 but not D4 receptor knockout mice (2009) (26)
- Immunohistochemical studies on phosphorylation of tyrosine hydroxylase in central catecholamine neurons using antibodies raised to phosphorylated forms of the enzyme (1997) (25)
- A model of the stress-induced activation of prefrontal cortical dopamine systems: Coping and the development of post-traumatic stress disorder. (1995) (25)
- Regionally-specific alterations in mesotelencephalic dopamine synthesis in diabetic rats: association with precursor tyrosine (2005) (24)
- The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat (2001) (19)
- Combination of diOlistic labeling with retrograde tract tracing and immunohistochemistry (2009) (18)
- The current status of neurotensin-dopamine interactions. Issues and speculations. (1992) (18)
- Immunohistochemical studies on phosphorylation of tyrosine hydroxylase in central catecholamine neurons using site- and phosphorylation state-specific antibodies. (1998) (18)
- [18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease (2018) (17)
- Amygdala Kindling Potentiates Seizure‐Stimulated Immediate‐Early Gene Expression in Rat Cerebral Cortex (1992) (17)
- A channel to neurodegeneration (2006) (17)
- Antibodies to a Segment of Tyrosine Hydroxylase Phosphorylated at Serine 40 (1995) (16)
- The effects of nigrostriatal dopamine depletion on the thalamic parafascicular nucleus (2012) (16)
- (Micro)Glia as Effectors of Cortical Volume Loss in Schizophrenia. (2018) (15)
- Identification of the neural systems subserving the actions of clozapine: clues from immediate-early gene expression. (1994) (15)
- Dopamine denervation of the prefrontal cortex increases expression of the astrocytic glutamate transporter GLT‐1 (2014) (15)
- Mesencephalic dopamine modulation of pituitary and central beta-endorphin: relation to food intake regulation. (1983) (14)
- Chapter 7 – Pharmacology and Biochemistry of Synaptic Transmission: Classical Transmitters (2014) (13)
- Is the loss of thalamostriatal neurons protective in parkinsonism? (2009) (13)
- TRANSPLANTS OF PRIMATE NEURONS (1986) (12)
- Amphetamine-elicited striatal Fos expression is attenuated in neurotensin null mutant mice (2006) (12)
- Profiling genes related to mitochondrial function in mice treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. (2003) (11)
- Editorial: The Claustrum: charting a way forward for the brain's most mysterious nucleus (2015) (11)
- Biochemical analysis of caudate nucleus biopsy samples from parkinsonian patients (1988) (10)
- Rat meningeal and brain microvasculature pericytes co-express the vesicular glutamate transporters 2 and 3 (2008) (10)
- Age- and duration-dependent effects of MPTP on cortical serotonin systems (2011) (8)
- CHAPTER 9 – Pharmacology and Biochemistry of Synaptic Transmission: Classic Transmitters (2004) (8)
- Localization of myocyte enhancer factor 2 in the rodent forebrain: Regionally-specific cytoplasmic expression of MEF2A (2009) (8)
- Neurochemistry of Schizophrenia (1999) (8)
- Hypertrophy of dopamine neurons in the primate following ventromedial mesencephalic tegmentum lesion (2004) (8)
- Regulation of A8 dopomine neurons by smuatostatin (1988) (7)
- Parkinson's disease redefined (2013) (6)
- Kainic acid stimulation of the lateral septum elicits tachycardia (1984) (5)
- REEPing the benefits of an animal model of hereditary spastic paraplegia. (2013) (5)
- Chapter 3.5 – Atypical antipsychotic drugs and stress (2005) (5)
- In Situ Hybridization Histochemistry of Tyrosine Hydroxylase Messenger RNA in Rat Brain (1988) (4)
- Neurochemical Systems in the Central Nervous System (2011) (4)
- Precursor Availability and Function of Midbrain Dopaminergic Neurons (1988) (3)
- Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain. (2017) (3)
- Chapter 6 – Neurotransmitters (2013) (2)
- The Therapeutic Potential of D1 and D2 Dopamine Agonists in Parkinson’S Disease (1988) (2)
- 192 Involvement of glutamatergic mechanisms in the biochemical actions of the atypical neuroleptic clozapine (1997) (1)
- Acute and subchronic MPTP administration differentially affect the serotonergic system in the striatum and prefrontal cortex (2007) (1)
- Neuroscience: Exploring the Brain (1999) (1)
- Synaptic Triad in the Neostriatum: Dopamine, Glutamate, and the MSN (2011) (1)
- Nonclassic Signaling in the Brain (2014) (1)
- Dopamine-Hypocretin/Orexin Interactions (2005) (1)
- The Thorny Problem of Dyskinesias: Dendritic Spines, Synaptic Plasticity, and Striatal Dysfunction (2014) (1)
- The Claustrum: charting a way forward for the brain’s most mysterious nucleus (2015) (1)
- A cautionary note on the potential benefits of striatal dopamineimplants (1990) (1)
- P2.001 Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervations (2009) (1)
- 220 The neurotensin agonist PD 149163 induces Fos protein expression in the prefrontal cortex: Similarities to atypical antipsychotic drugs (1997) (0)
- Effects of Prefrontal Cortical Dopamine Depletion on Parvalbumin-Containing GABAergic Interneurons (0)
- The Nucleus Accumbens Core and Shell: Accumbal Compartments and Their Functional Attributes (2019) (0)
- 190 Serotonergic modulation of the GABA system in the rat prefrontal cortex (1997) (0)
- Ultrastructure of Striatal Dopamine Synapses in Rats with Striatal Dopamine Depletion (2001) (0)
- The 3-Acetylpyridine Model of Parkinsonism: Use of Cytochrome Oxidase Gene Expression as an Index of Alterations in Basal Ganglia Function (1994) (0)
- Antibodies to synthetic peptides corresponding to segments of the dopamine da d 2 receptor (1990) (0)
- Age‐related changes in brain monoamines in a murine model of Parkinson's disease (2010) (0)
- Clinical Aspects of Schizophrenia (1999) (0)
- THE BIOLOGY OF NEGATIVE SYMPTOMS (1998) (0)
- CHAPTER 10 – Nonclassic Signaling in the Brain (2004) (0)
- Regulation of A8 dopamine neurons by somatostatin. (1988) (0)
- Cellular and Pharmacological Studies (1999) (0)
- Tuberculous Mothers and Nursing Infants (1910) (0)
- Extending Corticostriatal Systems. (2016) (0)
- Orexins rocketing to attention (2008) (0)
- 137. Microglial Pruning of Dendritic Spines in the Prefrontal Cortex During Adolescence (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ariel Y. Deutch?
Ariel Y. Deutch is affiliated with the following schools:
